Hypertension (high blood pressure) decisions — 2025

The Board granted service connection for diabetes mellitus, type II and hypertension based on the evidence of record at the time of the July 2025 rating decision.

The Board denied service connection for chronic fatigue syndrome (CFS) and remanded claims for a disability manifested by shortness of breath, hypertension, diabetes mellitus, type II, and left lower neuropathy.

The Board denied the veteran's claims for increased ratings and service connection, finding that his respiratory disorder, allergic rhinitis, chronic headaches, hypertension, and middle back sprain did not meet the criteria for higher disability ratings.

The Board denied service connection for various disabilities, including gastrointestinal issues, foot problems, ED, hemorrhoids, hernia, hypertension, nerve conditions in the lower extremities, shoulder and thumb issues, except for right ear hearing loss which was granted.

The Board granted service connection for tinnitus but denied service connection for hypertension and obstructive sleep apnea.

The Board denied an effective date earlier than April 24, 2024, for the award of service connection for hypertension.

The Board denied the Veteran's petitions to readjudicate claims for service connection for bradycardia, diabetes mellitus, hypertension, emphysema, hypothyroidism, polypectomy, prostate cancer, and rheumatoid arthritis as new and relevant evidence was not received. The claim for an acquired psychiatric disability is remanded.

The Board granted a 70 percent rating for depressive disorder with anxiety and insomnia, but denied an initial compensable rating for dental teeth seven, eight, and nine. The issues of service connection for hypertension and left ear hearing loss were remanded.

The Board remands the claims for an initial compensable evaluation for hypertension, TDIU, and service connection for various secondary conditions due to a pre-decisional duty-to-assist error.

The Board remands the claims for service connection for obstructive sleep apnea, diabetes mellitus, and hypertension as secondary to PTSD, as well as the claim for a higher initial rating for right knee disability and TDIU prior to May 10, 2022.

The Board denied service connection for the cause of the Veteran's death, finding no evidence linking his death to his military service.

The Board denied service connection for an acquired psychiatric disorder, a sleep disorder, and hypertension. The claim for a rating in excess of 50 percent for bilateral hearing loss was remanded.

The Board remands the claim for service connection for hypertension to provide the Veteran with notice of his right to a hearing before the AOJ.

The Board denied a compensable evaluation for hypertension but granted a total disability evaluation due to individual unemployability (TDIU) from February 7, 2025.

The Board granted the Veteran an initial rating of 10 percent for service-connected hypertension, effective from May 2, 2023.

The Board denied the veteran's claim for an initial compensable rating for hypertension, as the evidence did not show diastolic pressure predominantly 100 or more, systolic pressure predominantly 160 or more, or a history of such with continuous medication.

The Board denied the Veteran's appeal for an initial compensable rating for hypertension, as the evidence did not show that his diastolic pressure was predominantly 100 or more, systolic pressure was predominantly 160 or more, or required continuous medication.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) due to service-connected disabilities, finding that the evidence did not support a conclusion that his service-connected conditions prevented him from securing or following substantially gainful employment.

The Board denied service connection for a back disability, and remanded claims for respiratory condition, cataracts, diabetes mellitus, and hypertension.

The Board denied an effective date prior to August 10, 2022 for the award of service connection for valvular heart disease with cardiomyopathy and atrial fibrillation, sleep apnea, hypertension, erectile dysfunction, and male testis hypogonadism.